Does RESLIZUMAB Cause Dyspnoea? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Dyspnoea have been filed in association with RESLIZUMAB (CINQAIR). This represents 13.9% of all adverse event reports for RESLIZUMAB.
86
Reports of Dyspnoea with RESLIZUMAB
13.9%
of all RESLIZUMAB reports
0
Deaths
26
Hospitalizations
How Dangerous Is Dyspnoea From RESLIZUMAB?
Of the 86 reports, 26 (30.2%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RESLIZUMAB. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does RESLIZUMAB Cause?
Asthma (82)
Drug ineffective (80)
Incorrect dose administered (63)
Hypertension (47)
Headache (41)
Wheezing (40)
Cough (36)
Oropharyngeal pain (31)
Fatigue (29)
Myalgia (29)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which RESLIZUMAB Alternatives Have Lower Dyspnoea Risk?
RESLIZUMAB vs RESMETIROM
RESLIZUMAB vs RESTASIS
RESLIZUMAB vs RETINOL
RESLIZUMAB vs REVATIO
RESLIZUMAB vs REVEFENACIN